Patriot Financial Group Insurance Agency’s Alnylam Pharmaceuticals ALNY Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8	Closed	-$1K	–	462
2022 Q2	$1K	Sell	8 -177	-96%	-$25.1K	﹤0.01%	1851
2022 Q1	$30K	Buy	185 +5	+3%	+$762	0.01%	939
2021 Q4	$31K	Sell	180 -113	-39%	-$21K	0.01%	1038
2021 Q3	$55K	Buy	293 +48	+20%	+$9K	0.01%	836
2021 Q2	$42K	Buy	245 +53	+28%	+$7.76K	0.01%	896
2021 Q1	$27K	Buy	+192	New	+$28.9K	0.01%	978

Other funds holding ALNY

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Patriot Financial Group Insurance Agency's ALNY Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2022, closing a stake of 8 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in ALNY in Q1 2021 and held it in 6 quarters. The position peaked at $55K in Q3 2021. 497 funds tracked by Wall St. Rank hold ALNY as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining Alnylam Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 8 Alnylam Pharmaceuticals shares in Q3 2022, an estimated $1K.
Patriot Financial Group Insurance Agency first reported a position in Alnylam Pharmaceuticals in Q1 2021 and held it in 6 quarters.
Patriot Financial Group Insurance Agency's Alnylam Pharmaceuticals position peaked at $55K in Q3 2021.
497 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.